Oler Abraham N. (CIK 0001557372)

Latest company ownership

TRAW - Traws Pharma, Inc.
Role: SVP Corp Dev & Gen Counsel
Shares held
17,633
Last filed at
Feb 9, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 28, 2022 Jan 31, 2022 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 85.0 +1,500 6.52% ✓ $2.5K
Jan 21, 2022 Jan 24, 2022 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 85.0 +1,500 6.97% ✓ $3K
Jan 14, 2022 Jan 18, 2022 Traws Pharma, Inc. SVP CORP DEV & GEN COUNSEL Buy 85.0 +1,500 7.49% ✓ $3.3K
Jan 7, 2022 Jan 10, 2022 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 85.0 +1,500 8.10% ✓ $3.6K
Nov 19, 2021 Nov 23, 2021 Traws Pharma, Inc. SVP CORP DEV & GEN COUNSEL Buy 85.0 +1,000 5.71% ✗ $3.2K
Sep 28, 2021 Sep 29, 2021 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 91.3 +2,381 23.50% ✗ $10K
Feb 16, 2021 Feb 17, 2021 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 86.3 +12,000 8.57% ✗ $12K
Dec 11, 2020 Dec 14, 2020 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 90.0 +30,000 27.27% ✗ $9.6K
Nov 25, 2020 Nov 30, 2020 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 90.0 +20,000 22.22% ✗ $5.1K
May 19, 2020 May 20, 2020 Traws Pharma, Inc. SVP Corp Dev & Gen Counsel Buy 90.0 +15,000 20.00% ✗ $5.6K
Nov 25, 2019 Nov 26, 2019 Traws Pharma, Inc. VP Corp Dev & Gen Counsel Buy 91.3 +75,000 100.00% ✗ $15K